CancerQuest | Interview with Dr. Fadlo Khuri

Dr. Fadlo Khuri
Deputy Director for Clinical and Translational Research,
Winship Cancer Institute
Professor and Chairman, Department of Hematology and Medical Oncology,
Emory University School of Medicine

Fadlo R. Khuri, MD, is Professor and Chairman of the Department of Hematology & Medical Oncology, Emory University School of Medicine. He also serves as Deputy Director for the Winship Cancer Institute of Emory University. Dr. Khuri holds the Roberto C. Goizueta Distinguished Chair for Cancer Research. He is a Professor of Otolaryngology, Medicine, and Pharmacology, and Co-Director of the Winship Cancer Institute’s Cancer Drug Discovery, Development, and Delivery Program. In this interview Dr. Khuri talks with us about 'Oncogene Addiction' and how this concept influences cancer drug development.

Questions and Answers

	About Dr. Khuri(Time: 11 sec)
	How did you first become interested in research as a career, and more specifically cancer research? (Time: 1 min 14 sec)
	How does your work as a clinician influence your work in the lab, and vice versa?(Time: 1 min 45 sec)
	Has a patient’s clinical course ever provided insight that you were able to take back and use in the lab?(Time: 1 min 39 sec)
	What is the current role of genetic testing in determining treatment plans?(Time: 1 min 57 sec)
	What is a proto-oncogene? What is an oncogene?(Time: 1 min 2 sec)
	What is a tumor suppressor?(Time: 57 sec)
	What is meant by the term ‘oncogene addiction’?(Time: 1 min 11 sec)
	How has the concept of ‘oncogene addiction’ influenced cancer drug development?(Time: 1 min 28 sec)
	How much influence does genetic testing currently have on your design of a treatment plan?(Time: 2 min 47 sec)
	What is the current state of research regarding the role of nutrition in chemoprevention?(Time: 3 min 2 sec)
	Have you worked with any potential chemoprevention agents in your lab?(Time: 1 min 19 sec)
	What is your view regarding complementing standard chemotherapy with natural agents?(Time: 2 min 10 sec)
	What do you think about the use of existing drugs, such as celecoxib and aspirin, for the prevention of cancer?(Time: 2 min 31 sec)
	Do you involve students in any of your research?(Time: 1 min 17 sec)
	Do you have any advice for students interested in cancer research?(Time: 2 min 38 sec)

Interview with Dr. Fadlo Khuri - 12/15/2010

Questions and Answers